glycyrrhizic acid has been researched along with Obesity in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ML; Leng, Y; Shen, JH; Shen, Y; Tang, J; Xu, TF; Ye, YL; Yin, HZ; Zhou, Z; Zou, HJ | 1 |
| Chen, W; Cui, S; Liu, F; Mao, B; Tang, X; Zhang, Q; Zhao, J | 1 |
| Dong, S; Huang, H; Liu, C; Sha, H; Wei, W; Yu, M | 1 |
| Abo El-Magd, NF; El-Karef, A; El-Mesery, M; El-Shishtawy, MM | 1 |
| Antoniv, A; Kanovska, L; Khukhlina, O; Mandryk, O; Smandych, V | 1 |
| Elvy Suhana, MR; Fairus, A; Farihah, HS; Ima Nirwana, S; Santhana, R; Tan, MH | 1 |
| Fujii, I; Hayashi, H; Hirai, Y; Honda, H; Ikutani, M; Matsunaga, T; Muraguchi, A; Nagai, Y; Okamoto, N; Takatsu, K; Tsuneyama, K; Watanabe, Y | 1 |
| bin Abdul Kadir, K; Eu, CH; Lim, WY; Ton, SH | 1 |
8 other study(ies) available for glycyrrhizic acid and Obesity
| Article | Year |
|---|---|
Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Body Weight; Diabetes Mellitus, Experimental; Fats; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Models, Molecular; Obesity; Phenylpropionates; PPAR gamma; Rats; Rats, Wistar | 2009 |
Ethanol Extract of Licorice Alleviates HFD-Induced Liver Fat Accumulation in Association with Modulation of Gut Microbiota and Intestinal Metabolites in Obesity Mice.
Topics: Animals; Diet, High-Fat; Dysbiosis; Ethanol; Gastrointestinal Microbiome; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Plant Extracts | 2022 |
High mobility group box-1 mediates hippocampal inflammation and contributes to cognitive deficits in high-fat high-fructose diet-induced obese rats.
Topics: Animals; Apoptosis; Cognition; Cognitive Dysfunction; Diet, High-Fat; Glycyrrhizic Acid; Hippocampus; HMGB Proteins; HMGB1 Protein; Inflammation; Interleukin-1beta; Interleukin-6; Male; Microglia; NF-kappa B; Obesity; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway.
Topics: Adipocytes; Adipose Tissue; Animals; Diet, High-Fat; Glycyrrhizic Acid; Inflammation; Insulin; Insulin Resistance; Liver; Male; NF-E2-Related Factor 2; Obesity; Oxidative Stress; Rats; Rats, Wistar; Receptor, Insulin | 2018 |
EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE.
Topics: Administration, Oral; Anti-Inflammatory Agents; Cysteine; Drug Administration Schedule; Drug Combinations; Extracellular Matrix; Glycine; Glycyrrhizic Acid; Humans; Injections, Intravenous; Non-alcoholic Fatty Liver Disease; Obesity; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Piper sarmentosum is comparable to glycyrrhizic acid in reducing visceral fat deposition in adrenalectomised rats given dexamethasone.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenalectomy; Animals; Anti-Obesity Agents; Disease Models, Animal; Glycyrrhizic Acid; Intra-Abdominal Fat; Male; Obesity; Phytotherapy; Piper; Plant Extracts; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2013 |
Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents; Carrier Proteins; Cell Line, Tumor; Chalcones; Diet, High-Fat; DNA-Binding Proteins; Glyburide; Glycyrrhiza uralensis; Glycyrrhizic Acid; Humans; Hypercholesterolemia; Inflammasomes; Inflammation; Insulin Resistance; Interleukin-1beta; Islet Amyloid Polypeptide; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Specific Pathogen-Free Organisms | 2014 |
Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Dietary Fats; Gene Expression Regulation, Enzymologic; Glycyrrhizic Acid; Homeostasis; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipid Metabolism; Lipids; Lipoprotein Lipase; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2010 |